Rockefeller Capital Management L.P. Grows Stake in Axon Enterprise, Inc $AXON

Rockefeller Capital Management L.P. boosted its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 53.2% during the fourth quarter, Holdings Channel.com reports. The fund owned 11,518 shares of the biotechnology company’s stock after buying an additional 4,002 shares during the quarter. Rockefeller Capital Management L.P.’s holdings in Axon Enterprise were worth $6,542,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the stock. Creative Financial Designs Inc. ADV bought a new position in Axon Enterprise in the fourth quarter valued at $28,000. Sound Income Strategies LLC increased its stake in shares of Axon Enterprise by 550.0% in the fourth quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock worth $30,000 after buying an additional 44 shares during the period. Camelot Portfolios LLC bought a new position in shares of Axon Enterprise during the fourth quarter valued at about $30,000. AlphaCentric Advisors LLC bought a new position in Axon Enterprise during the 4th quarter valued at approximately $34,000. Finally, Lodestone Wealth Management LLC bought a new position in shares of Axon Enterprise during the fourth quarter valued at approximately $35,000. Institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling at Axon Enterprise

In related news, Director Caitlin Elizabeth Kalinowski sold 564 shares of the firm’s stock in a transaction on Monday, June 1st. The shares were sold at an average price of $478.97, for a total value of $270,139.08. Following the completion of the transaction, the director directly owned 3,632 shares of the company’s stock, valued at approximately $1,739,619.04. This trade represents a 13.44% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Elizabeth Reid Coughlin sold 1,554 shares of the business’s stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $485.00, for a total transaction of $753,690.00. Following the completion of the sale, the insider owned 34,024 shares in the company, valued at $16,501,640. This represents a 4.37% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 38,989 shares of company stock worth $19,090,083. Company insiders own 4.20% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have commented on AXON. Citizens Jmp restated a “market outperform” rating and issued a $700.00 price objective on shares of Axon Enterprise in a report on Thursday. The Goldman Sachs Group set a $535.00 price target on shares of Axon Enterprise in a research note on Thursday, May 7th. Morgan Stanley set a $600.00 price objective on Axon Enterprise in a research report on Thursday, May 7th. UBS Group dropped their price target on shares of Axon Enterprise from $570.00 to $440.00 and set a “neutral” rating on the stock in a report on Thursday, May 7th. Finally, Barclays dropped their price target on Axon Enterprise from $682.00 to $523.00 and set an “overweight” rating on the stock in a research note on Friday, May 8th. One research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $712.75.

Axon Enterprise Trading Up 4.6%

Shares of Axon Enterprise stock opened at $465.12 on Friday. Axon Enterprise, Inc has a twelve month low of $339.01 and a twelve month high of $885.91. The company has a quick ratio of 1.93, a current ratio of 2.27 and a debt-to-equity ratio of 0.49. The business has a 50-day moving average price of $420.65 and a 200-day moving average price of $482.08. The firm has a market cap of $37.49 billion, a price-to-earnings ratio of 186.79, a PEG ratio of 8.09 and a beta of 1.45.

Axon Enterprise (NASDAQ:AXON) last posted its earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 EPS for the quarter, topping analysts’ consensus estimates of $1.60 by $0.01. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.The company had revenue of $807.35 million for the quarter, compared to the consensus estimate of $778.90 million. During the same period in the previous year, the business earned $1.47 earnings per share. The firm’s revenue for the quarter was up 33.7% on a year-over-year basis. Equities research analysts anticipate that Axon Enterprise, Inc will post 1.82 EPS for the current fiscal year.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.